SEROPREVALENCE OF HIV INFECTION AMONG IV DRUG USERS IN SELECTED CITIES

Forms and Documents

Document	Type	Status	Availability

No forms / supporting documents in this ICR. Check IC Document Collections.

IC Document Collections

IC ID	Collection	Type	Status	Form
111999	SEROPREVALENCE OF HIV INFECTION AMONG IV DRUG USERS IN SELECTED CITIES		Migrated

ICR Details

OMB Control No: 0930-0128	ICR Reference No: 198712-0930-003
Status: Historical Active	Previous ICR Reference No:
Agency/Subagency: HHS/SAMHSA	Agency Tracking No:
Title: SEROPREVALENCE OF HIV INFECTION AMONG IV DRUG USERS IN SELECTED CITIES
Type of Information Collection: New collection (Request for a new OMB Control Number)	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 03/01/1988
	Date Received in OIRA: 12/15/1987
Terms of Clearance: This informstion collection request is approved subject to the following: (1) NIDA must develop a methodology for assessing non-response bias, to assess this bias NIDA should initiate blind seroprevalence testing at a minimum of two sites (one with a high infection rate and one with a low infection rate), if there is a significant difference between the infection rate for survey respondents and the blinded blood samples, then additional steps must be taken to assess the bias before data collection continues - including reconsideration of the participation requirement that individuals be willing to know their HIV status. NIDA should submit this analysis to OMB by 1/15/89. (2) NIDA must be ready to initiate the blind testing discussed above before the third wave of the data collection begins otherwise the data collection must be postponed. (3)Once the second wave of the data collection has ended and the initial analysis of the data has been completed, NIDA should submit a preliminary report on its initial findings including discussions of response rates, item response utility and recommended changes in the survey instrument. This report is also due to OMB by 1/15/89. (4) NIDA will make changes in the instrument as discussed in its February 9, 1988 memo to PHS.

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	02/28/1991	02/28/1991
Responses	6,000	0	0
Time Burden (Hours)	6,000	0	0
Cost Burden (Dollars)	0	0	0

---

Abstract: THIS STUDY IS DESIGNED TO ESTABLISH AN ONGOING MONITORING SYSTEM TO ESTIMATE THE EXTENT OF HIV INFECTION AMONG INTRAVENOUS DRUG USERS IN SELECTED CITIES AND TO PROVI INFORMATION ON THE DEMOGRAPHIC AND BEHAVIORAL VARIABLES OF THIS POPULATION. THE STUDY WILL PROVIDE PREVALENCE RATES AND TRENDS IN SUPPORT OF FEDERAL PLANNING AND RESEARCH INTO THE PROBLEM OF AIDS AMON

---

Authorizing Statute(s): None

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:

---

Federal Register Notices & Comments

Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 1

IC Title	Form No.	Form Name
SEROPREVALENCE OF HIV INFECTION AMONG IV DRUG USERS IN SELECTED CITIES

---

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	6,000	0	0	6,000	0	0
Annual Time Burden (Hours)	6,000	0	0	6,000	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement:

---

Annual Cost to Federal Government: $0

Does this IC contain surveys, censuses, or employ statistical methods? No

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? Uncollected

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? Uncollected

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? Uncollected

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 12/15/1987

---